WebMD News Brief

Oxford Starts Human Clinical Trials for Vaccine

Influenza virus

May 4, 2020 - Today in the world of coronavirus news –

Researchers at the University of Oxford have started clinical trials with humans for a coronavirus vaccine and might have results in a couple of months, the university said in a news release.

The school said around 1,110 people who have not tested positive for COVID-19 will participate, with half receiving the vaccine and the other half -- the control group -- receiving a meningitis vaccine. Participants will keep a diary and have blood samples taken to show how they’re responding to the vaccine.

To determine if the vaccine works, infection rates between the two groups will be compared. A number of participants will need to develop COVID-19, the release said.

“If transmission remains high, we may get enough data in a couple of months to see if the vaccine works, but if transmission levels drop, this could take up to 6 months,” the release said.

Oxford professor John Bell told the BBC that researchers “hope to get some signal about whether it's working by the middle of June."

Drug manufacturer AstraZeneca has agreed to distribute the vaccine if it works, the company said in a news release.

WebMD Health News Brief Reviewed by Michael W. Smith, MD on May 04, 2020

Sources

Oxford University

BBC

AstraZeneca

© 2020 WebMD, LLC. All rights reserved.